Pfizer Net Down on Lower Sales, Higher Research, Legal Costs by THE ASSOCIATED PRESS

By THE ASSOCIATED PRESS

Pfizer Inc.’s fourth-quarter profit fell by half as worsening generic competition and unfavorable currency rates reduced sales, and higher research spending and legal costs also hurt the bottom line.

Published: January 27, 2015 at 03:34AM

from NYT Business Day http://ift.tt/1D2OYvr

from WordPress http://ift.tt/1JWpW3y